THERAPLAS Trademark
Trademark Overview
On Wednesday, March 8, 2023, a trademark application was filed for THERAPLAS with the United States Patent and Trademark Office. The USPTO has given the THERAPLAS trademark a serial number of 97828627. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, April 29, 2025. This trademark is owned by Imunon, Inc.. The THERAPLAS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Development of platform technology, namely, cancer immunotherapy, infectious disease, and gene therapy platforms for manufacturing therapeutics; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; development of pharmaceutical preparations for treating cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology
General Information
| Serial Number | 97828627 |
| Word Mark | THERAPLAS |
| Filing Date | Wednesday, March 8, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, April 29, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 4, 2025 |
Trademark Statements
| Goods and Services | Development of platform technology, namely, cancer immunotherapy, infectious disease, and gene therapy platforms for manufacturing therapeutics; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; development of pharmaceutical preparations for treating cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 28, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Imunon, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Lawrenceville, NJ 08648 |
| Party Name | Imunon, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Lawrenceville, NJ 08648 |
Trademark Events
| Event Date | Event Description |
| Saturday, March 11, 2023 | NEW APPLICATION ENTERED |
| Tuesday, March 28, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, December 6, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, December 13, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 13, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, December 13, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 13, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 13, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 22, 2024 | SUSPENSION LETTER WRITTEN |
| Monday, April 22, 2024 | LETTER OF SUSPENSION E-MAILED |
| Monday, April 22, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, February 11, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 26, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 4, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 4, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 29, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, January 24, 2025 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
